GlaxoSmithKline PLC (GSK.L, GSK) reported that its third-quarter core operating profit was 2.32 billion pounds, 13% higher in CER terms than in prior year. Core earnings per share for the quarter was up 12% CER to 32.0 pence. Total basic earnings per share was 16.6 pence, down 1% CER, primarily reflecting charges arising from increases in the valuations of the liabilities for contingent consideration and the put options associated with increases in the Sterling value of the Group's Consumer Healthcare and HIV businesses, partly offset by improved core performance and reduced restructuring costs.
from RTT - Earnings http://ift.tt/2eLbWTz
via IFTTT
No comments:
Post a Comment